Traditional licorice-milk processing of Alangium chinense (Lour.) Harms reduces hepatotoxicity and enhances bioactivity via EGFR/PI3K/AKT pathway modulation.

IF 6.8 2区 医学 Q1 CHEMISTRY, MEDICINAL
Xinyue Wang, Dan Nie, Tingting Feng, Xiongwei Liu, Yizhen Liu, Jingyi Sun, Ying Zhou, Hongxi Xu, Chang Liu
{"title":"Traditional licorice-milk processing of Alangium chinense (Lour.) Harms reduces hepatotoxicity and enhances bioactivity via EGFR/PI3K/AKT pathway modulation.","authors":"Xinyue Wang, Dan Nie, Tingting Feng, Xiongwei Liu, Yizhen Liu, Jingyi Sun, Ying Zhou, Hongxi Xu, Chang Liu","doi":"10.1016/j.jep.2026.122532","DOIUrl":null,"url":null,"abstract":"<p><strong>Ethnopharmacological relevance: </strong>Alangium chinense (Lour.) Harms (AC) is a traditional Miao medicinal plant widely used to treat rheumatic and inflammatory disorders. Despite its therapeutic benefits, AC exhibits hepatotoxicity, limiting its safe clinical application. Traditional processing with licorice and milk has been historically employed to reduce toxicity and enhance efficacy, yet its chemical basis and underlying mechanisms remain incompletely understood.</p><p><strong>Aim of the study: </strong>This study aimed to elucidate how licorice-milk processing alters the chemical composition of AC, identify key blood-absorbed constituents, and clarify the mechanisms underlying detoxification and efficacy enhancement.</p><p><strong>Materials and methods: </strong>AC was processed using an optimized licorice-milk decoction via a multi-index orthogonal design. Toxicological and pharmacological effects of raw (RAC) and processed AC (PAC) were evaluated in rats through serum biochemistry, histopathology, and xylene-induced ear edema assays. UPLC-MS/MS-based metabolomics and serum pharmacochemistry identified chemical and blood-absorbed constituents. Network pharmacology, molecular docking, and Western blotting were employed to analyze hepatotoxicity-related targets and validate the involvement of signaling pathways.</p><p><strong>Results: </strong>Processing significantly altered the chemical profile of AC, reducing total toxic alkaloids by 27.1% while increasing flavonoids and phenols by 14.8% and 50.2%, respectively. PAC significantly decreased rat serum AST, ALT, and ALP levels, mitigated hepatic tissue injury, and inhibited xylene-induced ear edema. Metabolomic analysis identified 56 differential compounds, with 16 unique to PAC. Serum pharmacochemistry revealed 175 blood-absorbed components, 27 of which were differentially associated with hepatotoxicity, including 18β-glycyrrhetinic acid, enoxolone, and anabasine. Network pharmacology highlighted the EGFR/PI3K/AKT cascade as a core network. Molecular docking and 100-ns MD simulations demonstrated that representative compounds formed thermodynamically stable complexes within the active site of the downstream kinase AKT1 (backbone RMSD ≈ 0.238 - 0.246 nm). Tissue-level Western blotting demonstrated that PAC modulated the aberrant expression of EGFR, p-PI3K/PI3K, and p-AKT/AKT induced by RAC, suggesting the potential involvement of this axis in mitigating hepatotoxicity.</p><p><strong>Conclusion: </strong>Licorice-milk processing of AC mitigates hepatotoxicity while preserving anti-inflammatory efficacy by modulating toxic alkaloids and protective metabolites. The attenuation of liver toxicity is closely associated with the systemic regulation of the EGFR/PI3K/AKT signaling pathway. These findings provide dynamic biophysical insights into traditional processing and support the safe clinical application of AC.</p>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":" ","pages":"122532"},"PeriodicalIF":6.8000,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of ethnopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jep.2026.122532","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Ethnopharmacological relevance: Alangium chinense (Lour.) Harms (AC) is a traditional Miao medicinal plant widely used to treat rheumatic and inflammatory disorders. Despite its therapeutic benefits, AC exhibits hepatotoxicity, limiting its safe clinical application. Traditional processing with licorice and milk has been historically employed to reduce toxicity and enhance efficacy, yet its chemical basis and underlying mechanisms remain incompletely understood.

Aim of the study: This study aimed to elucidate how licorice-milk processing alters the chemical composition of AC, identify key blood-absorbed constituents, and clarify the mechanisms underlying detoxification and efficacy enhancement.

Materials and methods: AC was processed using an optimized licorice-milk decoction via a multi-index orthogonal design. Toxicological and pharmacological effects of raw (RAC) and processed AC (PAC) were evaluated in rats through serum biochemistry, histopathology, and xylene-induced ear edema assays. UPLC-MS/MS-based metabolomics and serum pharmacochemistry identified chemical and blood-absorbed constituents. Network pharmacology, molecular docking, and Western blotting were employed to analyze hepatotoxicity-related targets and validate the involvement of signaling pathways.

Results: Processing significantly altered the chemical profile of AC, reducing total toxic alkaloids by 27.1% while increasing flavonoids and phenols by 14.8% and 50.2%, respectively. PAC significantly decreased rat serum AST, ALT, and ALP levels, mitigated hepatic tissue injury, and inhibited xylene-induced ear edema. Metabolomic analysis identified 56 differential compounds, with 16 unique to PAC. Serum pharmacochemistry revealed 175 blood-absorbed components, 27 of which were differentially associated with hepatotoxicity, including 18β-glycyrrhetinic acid, enoxolone, and anabasine. Network pharmacology highlighted the EGFR/PI3K/AKT cascade as a core network. Molecular docking and 100-ns MD simulations demonstrated that representative compounds formed thermodynamically stable complexes within the active site of the downstream kinase AKT1 (backbone RMSD ≈ 0.238 - 0.246 nm). Tissue-level Western blotting demonstrated that PAC modulated the aberrant expression of EGFR, p-PI3K/PI3K, and p-AKT/AKT induced by RAC, suggesting the potential involvement of this axis in mitigating hepatotoxicity.

Conclusion: Licorice-milk processing of AC mitigates hepatotoxicity while preserving anti-inflammatory efficacy by modulating toxic alkaloids and protective metabolites. The attenuation of liver toxicity is closely associated with the systemic regulation of the EGFR/PI3K/AKT signaling pathway. These findings provide dynamic biophysical insights into traditional processing and support the safe clinical application of AC.

香茅甘草乳传统加工工艺通过调节EGFR/PI3K/AKT通路降低肝毒性并增强生物活性。
民族药理学相关性:Alangium chinense (Lour.)紫荆是一种传统的苗族药用植物,广泛用于治疗风湿病和炎症性疾病。尽管具有治疗效果,但AC具有肝毒性,限制了其安全的临床应用。历史上,甘草和牛奶的传统加工一直被用来降低毒性和提高功效,但其化学基础和潜在机制仍不完全清楚。研究目的:本研究旨在阐明甘草牛奶加工如何改变AC的化学成分,确定关键的血液吸收成分,并阐明其解毒和增强功效的机制。材料与方法:采用多指标正交设计,以优化后的甘草乳汁为原料,对甘草乳汁进行加工。通过大鼠血清生化、组织病理学和二甲苯致耳水肿实验,评价了原料AC (RAC)和加工AC (PAC)的毒理学和药理作用。基于UPLC-MS/ ms的代谢组学和血清药物化学鉴定了化学成分和血液吸收成分。采用网络药理学、分子对接、Western blotting等方法分析肝毒性相关靶点,验证信号通路的参与。结果:处理显著改变了白芷的化学特征,总毒性生物碱降低了27.1%,总黄酮和酚类物质分别增加了14.8%和50.2%。PAC可显著降低大鼠血清AST、ALT和ALP水平,减轻肝组织损伤,抑制二甲苯所致耳部水肿。代谢组学分析鉴定出56种差异化合物,其中16种是PAC独有的。血清药物化学显示175种血液吸收成分,其中27种与肝毒性差异相关,包括18种β-甘草次酸、依诺洛酮和苦楝碱。网络药理学强调EGFR/PI3K/AKT级联是核心网络。分子对接和100-ns MD模拟表明,代表性化合物在下游激酶AKT1的活性位点(主链RMSD≈0.238 ~ 0.246 nm)内形成了热力学稳定的配合物。组织水平的Western blotting结果显示,PAC可调节RAC诱导的EGFR、p-PI3K/PI3K和p-AKT/AKT的异常表达,提示该轴可能参与减轻肝毒性。结论:甘草乳加工可通过调节毒性生物碱和保护性代谢物来减轻肝毒性,同时保持抗炎作用。肝毒性的减弱与EGFR/PI3K/AKT信号通路的全身调控密切相关。这些发现为传统工艺提供了动态的生物物理学见解,并支持了AC的安全临床应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of ethnopharmacology
Journal of ethnopharmacology 医学-全科医学与补充医学
CiteScore
10.30
自引率
5.60%
发文量
967
审稿时长
77 days
期刊介绍: The Journal of Ethnopharmacology is dedicated to the exchange of information and understandings about people''s use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions. Early people confronted with illness and disease, discovered a wealth of useful therapeutic agents in the plant and animal kingdoms. The empirical knowledge of these medicinal substances and their toxic potential was passed on by oral tradition and sometimes recorded in herbals and other texts on materia medica. Many valuable drugs of today (e.g., atropine, ephedrine, tubocurarine, digoxin, reserpine) came into use through the study of indigenous remedies. Chemists continue to use plant-derived drugs (e.g., morphine, taxol, physostigmine, quinidine, emetine) as prototypes in their attempts to develop more effective and less toxic medicinals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书